ArticleCancer biology & medicine2025
Optimal immunotherapy duration in advanced NSCLC: defining the ideal treatment window.
Kaibo Ding et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
this paperpooled itcites it